Residency · Portland, OR
Sponsored by Oregon Health & Science University (OHSU Health)
Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Nature · 2022 · 355 citations · Reid Thompson
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet (London, England) · 2022 · 224 citations · Howard Sandler
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Journal for immunotherapy of cancer · 2021 · 267 citations · Marka Crittenden
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
The Lancet. Oncology · 2022 · 165 citations · Howard Sandler
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
NPJ digital medicine · 2022 · 166 citations · Howard Sandler
Malnutrition risk screening in adult oncology outpatients: An ASPEN systematic review and clinical recommendations.
JPEN. Journal of parenteral and enteral nutrition · 2024 · 48 citations · Aaron Grossberg
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
NEJM evidence · 2023 · 114 citations · Howard Sandler
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.
The Lancet. Oncology · 2025 · 28 citations · Howard Sandler